IPO registrations (S-1, F-1) · Registrants
Niagen Bioscience, Inc.
- SEC CIK
- 1386570 · filings on EDGAR ↗
- Name on the registration
- ChromaDex Corp.
- Former names
- ChromaDex Corp. (2008–2025); CODY RESOURCES, INC. (2007–2008)
- Registration
- Form S-1, first filed 2010-08-18, last 2011-03-16; 2 initial registrations, 1 amendment
- Outcome
- Declared effective 2010-09-16
- Industry (SIC)
- Medicinal Chemicals & Botanical Products 2833
- Incorporated in
- DE
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, Los Angeles, CA 90024
- EIN
- 26-2940963
- Ticker
- NAGE (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Niagen Bioscience, Inc. on the corporate pages
Offering terms
- Shares offered
- 5,983,075
- Listing
- OTC under the symbol CDXC
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: ChromaDex Corp. EXACT (CIK (EXACT))
- SEC filer: ChromaDex Corp. EXACT (CIK (EXACT))
- Person page: Glenn L Halpryn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-08-18 | S-1 | S-1 (registration) | ChromaDex Corp. | 0001193125-10-192104 ↗ |
| 2010-09-15 | S-1/A | S-1/A (amendment) | ChromaDex Corp. | 0001193125-10-210137 ↗ |
| 2010-09-16 | EFFECT | EFFECT (declared effective) | ChromaDex Corp. | 9999999995-10-002716 ↗ |
| 2011-03-16 | S-1 | S-1 (registration) | ChromaDex Corp. | 0001193125-11-068854 ↗ |
| 2011-03-24 | EFFECT | EFFECT (declared effective) | ChromaDex Corp. | 9999999995-11-000757 ↗ |
| 2011-10-19 | EFFECT | EFFECT (declared effective) | ChromaDex Corp. | 9999999995-11-002981 ↗ |
| 2012-05-09 | EFFECT | EFFECT (declared effective) | ChromaDex Corp. | 9999999995-12-001475 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-03-16 | S-1 | registration statement | 5,983,075 | - | OTC CDXC | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| CHASSMAN MARGIE | TenPercentOwner | 2 | 2008 | ||
| Dabney Reid J D | Director | 8 | 2008–2015 | ||
| Dunkerley Hugh D P | Director | 9 | 2008–2015 | ||
| GERMAIN MARK | Director | 8 | 2008–2014 | ||
| Jaksch Frank L Jr | Director; Director,Officer; Director,Officer,TenPercentOwner | CEO; CEO, PRESIDENT; Chief Executive Office; Chief Executive Officer; CSO; EXECUTIVE CHAIRMAN OF BOARD; President and CEO | 40 | 2008–2026 | |
| Jaksch Kevin M | Director | 2 | 2008–2010 | ||
| Varvaro Thomas C | Director,Officer; Officer | CFO and Secretary; CFO, Secretary; CFO, TREASURER AND SECRETARY; Chief Finanical Officer | 16 | 2008–2016 | |
| BLOCK STEPHEN A | Director | 18 | 2008–2021 | ||
| Black Sheep FLP | TenPercentOwner | 1 | 2008 | ||
| Jaksch Tricia A | TenPercentOwner | 1 | 2008 | ||
| Brauser Michael | Director; Director,TenPercentOwner; TenPercentOwner | 20 | 2010–2014 | ||
| HALPRYN GLENN L | Director | 12 | 2010–2015 | person page Fuzzy | |
| Frost Gamma Investments Trust | TenPercentOwner | 10 | 2010–2014 | ||
| FROST PHILLIP MD ET AL | TenPercentOwner | 10 | 2010–2014 | ||
| Spengler William | Director,Officer; Officer | President; PRESIDENT | 8 | 2010–2011 | |
| Lockshin Curtis | Director | 4 | 2011–2012 | ||
| Honig Barry C | Director | 23 | 2011–2014 | ||
| Himmel Jeffrey | Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 5 | 2012 | |
| Heim Debra | Officer | COO | 1 | 2012 | |
| Allen Stephen R. | Director | 9 | 2014–2017 | ||
| Rhonemus Troy Allen | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER; EXECUTIVE VICE PRESIDENT | 10 | 2014–2018 | |
| Baxter Jeff | Director | 8 | 2015–2021 | ||
| Fried Robert N | Director; Director,Officer | CEO; Cheif Executive Officer; Chief Executive Officer; PRESIDENT, CHIEF STRATEGY OFF.; PRESIDENT, COO; PRESIDENT, COO, CSO | 36 | 2015–2026 | |
| SMITHBURG WILLIAM D | Director | 1 | 2016 | ||
| GUSTAFSON KURT A | Director | 7 | 2016–2021 | ||
| Rubin Steven D | Director | 13 | 2017–2026 | ||
| Champion River Ventures Ltd | Director,TenPercentOwner; TenPercentOwner | 8 | 2017–2024 | ||
| Chau Hoi Shuen Solina Holly | TenPercentOwner | 8 | 2017–2024 | ||
| Li Ka Shing | TenPercentOwner | 6 | 2017–2024 | ||
| Pioneer Step Holdings Ltd | TenPercentOwner | 8 | 2017–2024 | ||
| Mayspin Management Ltd | Director,TenPercentOwner; TenPercentOwner | 7 | 2017–2024 | ||
| Prime Tech Global Ltd | Director,TenPercentOwner; TenPercentOwner | 7 | 2017–2024 | ||
| LAU Tsz Ho Tony | Director | 6 | 2017–2021 | ||
| YU Wing Tak Wendy | Director | 11 | 2017–2026 | ||
| FARR KEVIN M | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 15 | 2017–2022 | |
| Friedman Mark J | Officer | General Counsel; GENERAL COUNSEL | 6 | 2018–2020 | |
| Bratkovich Lisa | Officer | CHIEF MARKETING OFFICER | 3 | 2018–2019 | |
| Roberts Matthew A | Officer | CHIEF SCIENTIFIC OFFICER | 3 | 2018–2019 | |
| Jordan Megan Kern | Officer | SVP Global Mktg Chf Commns Ofc | 1 | 2020 | |
| Dvorak International Ltd | TenPercentOwner | 5 | 2020–2024 | ||
| Harrington Lisa Hatton | Officer | General Counsel; GENERAL COUNSEL | 2 | 2021 | |
| Levy Caroline S | Director | 2 | 2021 | ||
| Ng Wang Yu Gary | Director | 7 | 2021–2026 | ||
| Cohen Ann | Director | 7 | 2022–2026 | ||
| Patrick Kristin | Director | 8 | 2022–2026 | ||
| Gerber Brianna | Officer | Chief Financial Officer; SVP Finance / Interim CFO | 6 | 2022–2024 | |
| Shahbazi Hamed | Director | 6 | 2022–2026 | ||
| SHING LI KA | Director,TenPercentOwner; TenPercentOwner | 2 | 2022–2023 | ||
| Lee Jeong James | Officer | Interim CFO | 1 | 2024 | |
| Brilliant Dynasty Ltd | TenPercentOwner | 1 | 2024 | ||
| Elgar International Ltd | TenPercentOwner | 1 | 2024 | ||
| Radiant Treasure Ltd | TenPercentOwner | 1 | 2024 | ||
| Skyinvest Associates Ltd | TenPercentOwner | 1 | 2024 | ||
| Winsave Resources Ltd | TenPercentOwner | 1 | 2024 | ||
| Pamir Ozan | Officer | Chief Financial Officer | 7 | 2024–2026 | |
| Lopez Carlos Luis | Officer | SVP, General Counsel | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-10-14 | ChromaDex Corp. | Biotechnology | $3,100,000 | $3,100,000 | 3 | 1 |
| 2021-03-03 | ChromaDex Corp. | Biotechnology | $24,999,995 | $24,999,995 | 1 | 1 |
| 2020-05-20 | ChromaDex Corp. | Biotechnology | $5,000,000 | $5,000,000 | 2 | 1 |
| 2019-08-29 | ChromaDex Corp. | Biotechnology | $7,000,000 | $7,000,000 | 3 | 1 |
| 2019-05-24 | ChromaDex Corp. | Biotechnology | $10,000,000 | $10,000,000 | 2 | 1 |
| 2017-11-29 | ChromaDex Corp. | Biotechnology | $22,999,996 | $22,999,996 | 10 | 1 |
| 2017-08-31 | ChromaDex Corp. | Biotechnology | $5,110,084 | $5,110,084 | 2 | 1 |
| 2017-06-06 | ChromaDex Corp. | Biotechnology | $16,389,916 | $16,389,916 | 2 | 1 |
| 2017-05-05 | ChromaDex Corp. | Biotechnology | $3,500,000 | $3,500,000 | 2 | 1 |
| 2017-03-22 | ChromaDex Corp. | Biotechnology | $1,000,003 | $1,000,003 | 3 | 1 |
| 2016-03-16 | ChromaDex Corp. | Biotechnology | $500,000 | $500,000 | 1 | 1 |
| 2014-10-14 | ChromaDex Corp. | Biotechnology | $445,000 | $445,000 | 1 | 1 |
| 2012-02-22 | ChromaDex Corp. | Biotechnology | $3,699,998 | $3,699,998 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | ChromaDex Corp. | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | Niagen Bioscience, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Glenn L Halpryn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Medicinal Chemicals & Botanical Products, CA first:
- MAXIM PHARMACEUTICALS INC CA
- CN BIOSCIENCES INC CA
- NATROL INC CA
- Marijuana Co of America, Inc. CA
- Huifeng Bio-Pharmaceutical Technology, Inc. CA
- Charlie's Holdings, Inc. CA
- BLOOMIOS, INC. CA
- ImmunoBiotics, Inc. CA
- ALPHA NETWORK ALLIANCE VENTURES INC. CA
- Genufood Energy Enzymes Corp. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Medicinal Chemicals & Botanical Products · Health